Acorah Software Products - Accounts Production 14.6.300 true true 8 January 2024 1 May 2023 false 9 January 2024 8 January 2025 8 January 2025 11936629 Mr Luke Powell iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11936629 2024-01-08 11936629 2025-01-08 11936629 2024-01-09 2025-01-08 11936629 frs-core:Non-currentFinancialInstruments 2025-01-08 11936629 frs-core:ShareCapital 2025-01-08 11936629 frs-core:RetainedEarningsAccumulatedLosses 2025-01-08 11936629 frs-bus:PrivateLimitedCompanyLtd 2024-01-09 2025-01-08 11936629 frs-bus:FilletedAccounts 2024-01-09 2025-01-08 11936629 frs-bus:SmallEntities 2024-01-09 2025-01-08 11936629 frs-bus:EntityNoLongerTradingButTradedInPast 2024-01-09 2025-01-08 11936629 frs-bus:AuditExempt-NoAccountantsReport 2024-01-09 2025-01-08 11936629 frs-bus:SmallCompaniesRegimeForAccounts 2024-01-09 2025-01-08 11936629 frs-bus:Director1 2024-01-09 2025-01-08 11936629 frs-countries:EnglandWales 2024-01-09 2025-01-08 11936629 2023-04-30 11936629 2024-01-08 11936629 2023-05-01 2024-01-08 11936629 frs-core:CurrentFinancialInstruments 2024-01-08 11936629 frs-core:Non-currentFinancialInstruments 2024-01-08 11936629 frs-core:ShareCapital 2024-01-08 11936629 frs-core:RetainedEarningsAccumulatedLosses 2024-01-08
Registered number: 11936629
Chaperone Surgery Limited
Unaudited Financial Statements
For The Year Ended 8 January 2025
Courtview Accounting Ltd
483 Green Lanes
London
N13 4BS
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: 11936629
8 January 2025 8 January 2024
Notes £ £ £ £
CURRENT ASSETS
Debtors 4 - 697
Cash at bank and in hand 697 -
697 697
NET CURRENT ASSETS (LIABILITIES) 697 697
TOTAL ASSETS LESS CURRENT LIABILITIES 697 697
Creditors: Amounts Falling Due After More Than One Year 5 (7,625 ) (7,625 )
NET LIABILITIES (6,928 ) (6,928 )
CAPITAL AND RESERVES
Called up share capital 6 100 100
Profit and Loss Account (7,028 ) (7,028 )
SHAREHOLDERS' FUNDS (6,928) (6,928)
For the year ending 8 January 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Luke Powell
Director
08/01/2025
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Chaperone Surgery Limited is a private company, limited by shares, incorporated in England & Wales, registered number 11936629 . The registered office is 8 Chenevare Mews, High Street, Kinver, Stourbridge, West Midlands, DY7 6HB.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2024: NIL)
- -
4. Debtors
8 January 2025 8 January 2024
£ £
Due within one year
Director's loan account - 697
5. Creditors: Amounts Falling Due After More Than One Year
8 January 2025 8 January 2024
£ £
Bounce back loan 7,625 7,625
6. Share Capital
8 January 2025 8 January 2024
£ £
Allotted, Called up and fully paid 100 100
7. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
The above loan is unsecured, interest free and repayable on demand.
Page 2